EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept

Johanna Jost-Engl iD, Ralf Ketter, Ralf Brandt, Klaus Völker, Joachim Gerß iD, Kathleen Jetschke, Carolin Weiss Lucas, Freerk T Baumann, Philipp M Lepper, Steffi Urbschat, Walter Stummer iD, Rainer Wiewrodt und 2 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Johanna Jost-Engl und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Research Division, Department of Medicine A, University Hospital, University Münster, Münster, Germany. Hauptthemen laut MEDLINE: Quality of Life, Glioma, Cardiorespiratory Fitness, Exercise Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Münster University Hospital Central Nervous System Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-grade glioma (HGG) patients experience enormous disease burden both from tumor- and treatment-related symptoms. Exercise can improve physical fitness and quality of life (QoL); yet experience in neuro-oncology, especially with high-intensity exercise, remains limited. This study evaluated feasibility, safety, and efficacy of the intensive, structured 16-week strength and endurance program, “Active in Neuro-Oncology” (ActiNO) for HGG patients undergoing chemotherapy.

Methods

In this prospective, oligocentric, single-arm proof-of-concept trial, 54 HGG patients participated in ActiNO, with twice-weekly supervised exercise sessions. The primary endpoint was cardiorespiratory fitness, assessed via physical working capacity (PWC75%)—the workload (W/kg body weight) achieved at 75% of age-adjusted maximum heart rate during a maximal cardiopulmonary exercise test. Secondary endpoints included peak oxygen uptake (VO2peak), peak power output (Ppeak), and QoL (EORTC QLQ-C30). Analyses focused on within-subject changes from pre- to post-intervention. Additionally, comparisons to normative data were performed. Feasibility was assessed via accrual, adherence, and attrition; safety via adverse event monitoring (CTCAE).

Results

Program tolerance was high, with few exercise-related adverse events (all CTCAE grade 1-2). Over 16 weeks, significant improvements were observed in PWC75% (1.023-1.256 W/kg BW, +23%), VO2peak (23.04-26.09 ml/min/kg BW, +13%), and Ppeak (1.771-2.104 W/kg BW, +19%). QoL, including global health and physical functioning, improved, reaching normative values. Adherence was high (85%), though attrition was 48%, mainly due to disease progression or physical constraints.

Conclusions

High-intensity exercise is feasible and safe in HGG patients undergoing chemotherapy. The observed improvements in physical fitness and QoL support incorporating structured exercise into neuro-oncology care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeGliomaCardiorespiratory FitnessExercise TherapyBrain NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedProspective StudiesAdultAgedProof of Concept StudyFeasibility StudiesFollow-Up StudiesPrognosisNeoplasm Grading

Stichwörter der Autor:innen

Active in Neuro-Oncology (ActiNO)cardiopulmonary exercise testingglioblastomaphysical activitysupportive therapy

Autor:innen und Institutionen

  • Pulmonary Research Division, Department of Medicine A, University Hospital, University Münster, Münster, Germany.
  • Department of Neurosurgery, University Hospital, Saarland University, Homburg/Saar, Germany.
  • Department of Neurosurgery, University Hospital, University Münster, Münster, Germany.
  • Institute of Sports Science, University Hospital, University Münster, Münster, Germany.
  • Institute of Biostatistics and Clinical Research, University Münster, Münster, Germany.
  • Department of Neurosurgery, University Hospital Knappschaftskrankenhaus, Ruhr University Bochum, Bochum, Germany.

ORCID-Profile: Johanna Jost-Engl, Joachim Gerß, Walter Stummer, Dorothee Wiewrodt

Förderung

  • Münster University Hospital Central Nervous System Association

Zitieren

APA

Jost-Engl, J., Ketter, R., Brandt, R., Völker, K., Gerß, J., Jetschke, K., Weiss Lucas, C., Baumann, F. T., Lepper, P. M., Urbschat, S., Stummer, W., Wiewrodt, R., Wiewrodt, D., & MMH Trial Investigators (2025). Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf176

Vancouver

Jost-Engl J, Ketter R, Brandt R, Völker K, Gerß J, Jetschke K, et al. Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf176

BibTeX
@article{JostEngl2025,
  author = {Jost-Engl, Johanna and Ketter, Ralf and Brandt, Ralf and Völker, Klaus and Gerß, Joachim and Jetschke, Kathleen and Weiss Lucas, Carolin and Baumann, Freerk T and Lepper, Philipp M and Urbschat, Steffi and Stummer, Walter and Wiewrodt, Rainer and Wiewrodt, Dorothee and MMH Trial Investigators, MMH Trial Investigators},
  title = {Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf176}
}
Kostenlos starten →